Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
3.32 USD -22.61% Intraday chart for Revance Therapeutics, Inc. -15.95% -62.23%
May. 10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
May. 10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REVANCE THERAPEUTICS, INC.
Biopharmaceuticals
-22.61%-15.95%-62.23%-90.83%-73.71% 447M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. Relative Strength Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW